Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Empiric antituberculous therapy in patients with unexplained exsudative pleural effusion. Is it valid in Senegal?
Revue de Pneumologie Clinique, Volume 63, No. 4, Year 2007
Notification
URL copied to clipboard!
Description
Aim. Pleural biopsy and adenosine deaminase activity are not available at our center and the treatment begins without substantiation diagnosis in patients with tuberculous pleural effusion (PE). Methods. In order to evaluate the validity of an empiric antituberculous therapy in exsudative PE with high prevalence of lymphocytes, we conducted a retrospective study during 1 year. Patient was enrolled if no signs of tuberculous infection, pneumonia or cancer were present. Results. During 1 year, 38 patients were enrolled (23 males, mean age =36 years). PE was major (> 2/3 of the lung) in 14 cases, moderate (between 1/3 and 2/3) In 18 cases and minor (< 1/3) in 6 cases. Tuberculous contagion was observed in 10 patients. Tuberculinic test was positive in all patients (1224 mm). Clinical and radiological cure was obtained in 37 cases, except 1 patient who died from acute heart failure. No recurrence of PE was observed after 1 year follow-up. Conclusion. In our endemic areas, empiric antituberculous treatment seems to be an effective strategy in patients with exsudative PE. © 2007. Elsevier Masson SAS.
Authors & Co-Authors
Sané, Mouhamadou
Senegal, Dakar
Hopital Principal de Dakar
France, Clamart
Hôpital D'instruction Des Armées Percy
Bâ-Fall, K. M.
Senegal, Dakar
Hopital Principal de Dakar
Lefebvre, Nicolas
Senegal, Dakar
Hopital Principal de Dakar
Mounguengui, D.
Senegal, Dakar
Hopital Principal de Dakar
Camara, Ph
Senegal, Dakar
Hopital Principal de Dakar
Niang, Abdourahmane R.
Senegal, Dakar
Hopital Principal de Dakar
France, Clamart
Hôpital D'instruction Des Armées Percy
Bonnichon, Augustin
France, Clamart
Hôpital D'instruction Des Armées Percy
Chevalier, Benoît
Senegal, Dakar
Hopital Principal de Dakar
Saliou-Mbaye, P.
Senegal, Dakar
Hopital Principal de Dakar
Debonne, Jean Marc
Senegal, Dakar
Hopital Principal de Dakar
Margery, J.
Senegal, Dakar
Hopital Principal de Dakar
France, Clamart
Hôpital D'instruction Des Armées Percy
France, Metz Armee
Hia Legouest
Statistics
Citations: 11
Authors: 11
Affiliations: 3
Identifiers
Doi:
10.1016/S0761-8417(07)92647-4
ISSN:
07618417
Research Areas
Cancer
Health System And Policy
Study Design
Cross Sectional Study
Cohort Study
Study Locations
Senegal